^
    BIOMARKER:
    MYC rearrangement + BCL2 rearrangement
    i
    Other names: MYC, bHLHe39, c-Myc, MYCC, V-myc avian myelocytomatosis viral oncogene homolog, BCL2, Bcl-2, PPP1R50, B-cell CLL/lymphoma 2
    Entrez ID:
    4609; 596
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others
    MYC rearrangement + BCL2 rearrangement
    Diffuse Large B Cell Lymphoma
    lisocabtagene maraleucel
    Sensitive
    :
    A2
    MYC rearrangement + BCL2 rearrangement
    Diffuse Large B Cell Lymphoma
    lenalidomide
    Sensitive
    :
    B
    MYC rearrangement + BCL2 rearrangement
    Diffuse Large B Cell Lymphoma
    cytarabine + methotrexate
    Resistant
    :
    C3
    MYC rearrangement + BCL2 rearrangement
    Diffuse Large B Cell Lymphoma
    rituximab
    Resistant
    :
    C3
    MYC rearrangement + BCL2 rearrangement
    Lymphoma
    lisocabtagene maraleucel
    Sensitive
    :
    C3
    MYC rearrangement + BCL2 rearrangement
    NHL
    ibrutinib
    Sensitive
    :
    C3
    MYC rearrangement + BCL2 rearrangement
    Follicular Lymphoma
    EPOCH-R
    Sensitive
    :
    C3
    MYC rearrangement + BCL2 rearrangement
    Follicular Lymphoma
    R-DHAP
    Sensitive
    :
    C3
    MYC rearrangement + BCL2 rearrangement
    Diffuse Large B Cell Lymphoma
    IACS-010759
    Sensitive
    :
    D
    MYC rearrangement + BCL2 rearrangement
    Diffuse Large B Cell Lymphoma
    ibrutinib
    Resistant
    :
    D
    MYC rearrangement + BCL2 rearrangement
    NHL
    ibrutinib + alemtuzumab
    Sensitive
    :
    D
    VERI is free for non-commercial use, no login needed.
    Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
    For commercial access, including additional premium features, please contact us.
    By using VERI, you are agreeing to our
    and
    Privacy Policy
    ACCEPT COOKIES